10 completed, 3 unknown, 2 recruiting, 2 withdrawn. 18 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 18 | Completed 10, Unknown 3, Recruiting 2, Withdrawn 2, Terminated 1 |
Follow The Alfred: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PeRiOperative Medicine Platform Trial Liberal inspired oxygen, Conservative inspired oxygen, Intermediate inspired oxygen - Surgical Site Infection After Major Surgery, Anaesthesia | Phase 4 | Recruiting | Monash University | 7800 | 2026-04-06 | 2026-04-17 |
| Bazedoxifene -Treatment for Women With Schizophrenia Bazedoxifene Acetate, Placebo - Schizophrenia, Schizophreniform Disorders | Phase 4 | Recruiting | The Alfred | 160 | 2019-10-07 | 2026-06-03 |
| Volatile Anaesthesia and Perioperative Outcomes Related to Cancer Feasibility Study Propofol, isoflurane, sevoflurane or desflurane - Cancer, Breast, Cancer Colorectal | Phase 4 | Completed | Peter MacCallum Cancer Centre, Australia | 169 | 2017-08-27 | 2022-06-09 |
| Dolutegravir Impact on Residual Replication dolutegravir, Placebo - HIV | Phase 4 | Completed | University of Melbourne | 40 | 2015-09-28 | 2017-11-20 |
| CPET in CF Patients With One G551D Mutation Taking VX770 ivacaftor, placebo - Cystic Fibrosis | Phase 4 | Unknown | The Alfred | 20 | 2014-02-01 | 2016-07-25 |
| Cardiovascular Effects of Agomelatine and Escitalopram in Patients With Major Depressive Disorder (MDD) Agomelatine, Escitalopram - Major Depressive Disorder (MDD) | Phase 4 | Unknown | Baker Heart and Diabetes Institute | 40 | 2014-01-01 | 2013-12-18 |
| A Study Comparing Continuous Infusion Antibiotics to Standard Treatment for Lung Infections in Cystic Fibrosis Intermittent, short infusion Ceftazidime, Continuous infusion Ceftazidime, Intermittent, short infusion Meropenem - Cystic Fibrosis | Phase 4 | Unknown | The Alfred | 50 | 2012-09-01 | 2017-04-20 |
| Tibolone and Placebo in Adjunct to Antidepressant Medication for Women With Menopausal Depression Tibolone - Menopausal Depression | Phase 4 | Completed | The Alfred | 120 | 2012-07-01 | 2020-01-09 |
| Investigation of Tibolone and Escitalopram in Perimenopausal Depression Tibolone, Escitalopram, Natvia - Perimenopausal Depression | Phase 4 | Terminated | The Alfred | 2 | 2012-07-01 | 2015-03-31 |
| Alleviating the Metabolic Side Effects of Antipsychotic Medications Moxonidine, Placebo - Schizophrenia | Phase 4 | Withdrawn | Baker Heart and Diabetes Institute | 2012-05-01 | 2019-04-24 | |
| Major Depressive Disorder - Understanding The Link Between The Brain And The Heart Participants will be prescribed an approved selective serotonin re-uptake inhibitor (SSRI) antidepressant. - Major Depressive Disorder | Phase 4 | Completed | Baker Heart and Diabetes Institute | 80 | 2012-05-01 | 2023-09-14 |
| Aspirin Withdrawal in Non-ischaemic Cardiomyopathy Study Aspirin, withdrawal of aspirin - Heart Failure | Phase 4 | Completed | The Alfred | 12 | 2012-03-01 | 2016-06-01 |
| Selective Estrogen Receptor Modulators (SERMs) - A Potential Treatment for Psychotic Symptoms of Schizophrenia in Men? Raloxifene Hydrochloride, Placebo - Schizophrenia, Schizoaffective Disorder | Phase 4 | Completed | The Alfred | 13 | 2012-01-01 | 2023-11-28 |
| Selective Estrogen Receptor Modulators for Women of Child-bearing Age With Schizophrenia Raloxifene hydrochloride, Placebo - Schizophrenia, Schizoaffective Disorder | Phase 4 | Completed | The Alfred | 80 | 2011-04-01 | 2020-01-09 |
| Switch From Tenofovir to Raltegravir for Low Bone Mineral Density Raltegravir - HIV, Osteopenia | Phase 4 | Completed | St Vincent's Hospital, Sydney | 52 | 2009-10-01 | 2015-06-12 |
| Selective Estrogen Receptor Modulators - A Potential Treatment for Psychotic Symptoms of Schizophrenia Raloxifene hydrochloride, Lactose Capsules - Schizophrenia, Schizoaffective Disorder | Phase 4 | Completed | The Alfred | 54 | 2006-08-01 | 2015-01-30 |
| A Comparison of the Effect of Carvedilol and Metoprolol on Airways Tone in Patients With Heart Failure Carvedilol, Metoprolol - Heart Failure, Chronic Obstructive Airway Disease | Phase 4 | Withdrawn | The Alfred | 2005-06-01 | 2015-06-24 | |
| The Effect of N2O Administration on Arterial Oxygenation Nitrous oxide - Anesthesia | Phase 4 | Completed | Austin Health | 20 | 2005-03-01 | 2018-01-11 |
Schizophrenia (5) · Psychotic Disorders (4) · Mental Disorders (3) · Cystic Fibrosis (2) · Depression (2) · Depressive Disorder, Major (2) · Heart Failure (2) · Bone Diseases, Metabolic (1) · Breast Neoplasms (1) · Colonic Neoplasms (1) · HIV Infections (1) · Lung Neoplasms (1) · Melanoma (1) · Neoplasms (1) · Osteoporosis (1)
Lactose (3) · Raloxifene Hydrochloride (3) · Escitalopram (2) · tibolone (2) · Antidepressive Agents (1) · Aspirin (1) · Carvedilol (1) · Desflurane (1) · Isoflurane (1) · Metoprolol (1) · Nitrous Oxide (1) · Propofol (1) · Raltegravir Potassium (1) · Selective Serotonin Reuptake Inhibitors (1) · Sevoflurane (1)
Australia (17) · New Zealand (1)
David Barton (3) · Gavin Lambert (3) · Abdul Khalid (2) · Jayashri Kulkarni, PhD,FRANZP (2) · Andrew D Carr, Professor (1) · Anton Peleg, MBBS, FRACP. (1) · Daniel Frei, PhD (1) · Henry Krum, Professor (1) · Jayashri Kulkarni, MBBS, MPM, FRANZCP, PhD (1) · Jayashri Kulkarni, Phd,FRANZCP (1) · John Wilson (1) · Philip J Peyton, MD FANZCA (1) · Sharon Lewin (1) · Trisha Peel, PhD (1)
PMID 31415936, PMID 27438995, PMID 28611235, PMID 29643011, PMID 29723767, PMID 42701421
2025 (1)